UGT1A1*6 IS A PREDICTIVE MARKER OF SEVERE NEUTROPENIA FOR METASTATIC CRC PATIENTS RECEIVED FOLFIRI IN JAPAN

被引：0
|
作者：
Hazama, S. [1 ]
Okuyama, Y. [2 ]
Kato, T. [3 ]
Takahashi, K. [4 ]
Nozawa, H. [5 ]
Okayama, N. [6 ]
Hinoda, Y. [7 ]
Oka, M. [1 ]
Sakamoto, J. [8 ]
Mishima, H. [9 ]
机构：
[1] Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol, Ube, Yamaguchi 755, Japan
[2] Kyoto First Red Cross Hosp, Kyoto, Japan
[3] Minoh Municipal Hosp, Mino, Japan
[4] Akita City Hosp, Dept Surg, Akita, Japan
[5] Takaoka Hosp, Dept Surg, Takaoka, Toyama, Japan
[6] Yamaguchi Univ, Dept Clin Lab Sci, Ube, Yamaguchi, Japan
[7] Yamaguchi Univ, Grad Sch Med, Dept Clin Lab Sci, Ube, Yamaguchi 755, Japan
[8] Nagoya Univ, Grad Sch Med, Young Leaders Program, Nagoya, Aichi 4648601, Japan
[9] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Use of genotype subset selections of multi-UGT1As polymorphisms to predict severe neutropenia and tumor responses of metastatic CRC patients received FOLFIRI regimen
    Hazama, S.
    Okuyama, Y.
    Kato, T.
    Okayama, N.
    Hinoda, Y.
    Sakamoto, J.
    Mishima, H.
    Fujita, Y.
    Hamamoto, Y.
    Oka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Genotype subset selection of multi-UGT1As polymorphisms can predict severe neutropenia and tumour responses of metastatic CRC patients received FOLFIRI regimen
    Hazama, S.
    Oka, M.
    Hamamoto, Y.
    Fujita, Y.
    Hinoda, Y.
    Okayama, N.
    Okuyama, Y.
    Kato, T.
    Mishima, H.
    Sakamoto, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 354 - 354
  • [3] UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
    Masahide Onoue
    Tomohiro Terada
    Masahiko Kobayashi
    Toshiya Katsura
    Shigemi Matsumoto
    Kazuhiro Yanagihara
    Takafumi Nishimura
    Masashi Kanai
    Satoshi Teramukai
    Akira Shimizu
    Masanori Fukushima
    Ken-ichi Inui
    International Journal of Clinical Oncology, 2009, 14 : 136 - 142
  • [4] UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
    Onoue, Masahide
    Terada, Tomohiro
    Kobayashi, Masahiko
    Katsura, Toshiya
    Matsumoto, Shigemi
    Yanagihara, Kazuhiro
    Nishimura, Takafumi
    Kanai, Masashi
    Teramukai, Satoshi
    Shimizu, Akira
    Fukushima, Masanori
    Inui, Ken-ichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (02) : 136 - 142
  • [5] UGT1A1*6 AND UGT1A1*27 ARE ASSOCIATED WITH IRINOTECAN-INDUCED SEVERE NEUTROPENIA IN JAPANESE PATIENTS WITH NSCLC
    Doi, S.
    Nakamura, Y.
    Fukuda, M.
    Takatani, H.
    Fukuda, M.
    Kinoshita, A.
    Soda, H.
    Oka, M.
    Tsukamoto, K.
    Kohno, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 165 - 165
  • [6] UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan
    Hazama, Shoichi
    Mishima, Hideyuki
    Tsunedomi, Ryouichi
    Okuyama, Yusuke
    Kato, Takeshi
    Takahashi, Ken-ichi
    Nozawa, Hiroshi
    Ando, Hideaki
    Kobayashi, Michiya
    Takemoto, Hiroyoshi
    Nagata, Naoki
    Kanekiyo, Shinsuke
    Inoue, Yuka
    Hamamoto, Yoshihiko
    Fujita, Yusuke
    Hinoda, Yuji
    Okayama, Naoko
    Oba, Koji
    Sakamoto, Jun-ichi
    Oka, Masaaki
    CANCER SCIENCE, 2013, 104 (12) : 1662 - 1669
  • [7] Cost-effectiveness analysis of UGT1A1*6/*28 genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patients
    Wei, XiaoXia
    Cai, JiaQin
    Sun, Hong
    Li, Na
    Xu, Chenxia
    Zhang, Guifeng
    Sui, Yuxia
    Zhuang, Jie
    Zheng, Bin
    PHARMACOGENOMICS, 2019, 20 (04) : 241 - 250
  • [8] Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
    Fei-fei Han
    Chang-long Guo
    Dan Yu
    Jin Zhu
    Li-li Gong
    Guang-run Li
    Ya-li Lv
    He Liu
    Guang-yu An
    Li-hong Liu
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 779 - 788
  • [9] Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
    Han, Fei-fei
    Guo, Chang-long
    Yu, Dan
    Zhu, Jin
    Gong, Li-li
    Li, Guang-run
    Lv, Ya-li
    Liu, He
    An, Guang-yu
    Liu, Li-hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 779 - 788
  • [10] Cost-Effectiveness of UGT1A1*28 Genotyping in Preventing Severe Neutropenia Following FOLFIRI Therapy in Colorectal Cancer
    Pichereau, Solen
    Le Louarn, Anne
    Lecomte, Thierry
    Blasco, Helene
    Le Guellec, Chantal
    Bourgoin, Helene
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2010, 13 (04): : 615 - 625
12345